Collagen Peptides for Skin: What Trials and Reviews Report

Do collagen peptides help skin? What the published evidence shows

Across randomized placebo controlled trials and pooled analyses, oral hydrolyzed collagen has been associated with statistically significant improvements in instrument measured skin hydration and elasticity compared with placebo (PMID 33742704), and a later meta analysis of randomized controlled trials of oral collagen for skin aging reported improvements in the same two endpoints relative to control groups (PMID 37432180). Findings for wrinkle depth and roughness have been reported less consistently across studies, and a systematic review of dermatological applications of oral collagen described the available results as preliminary and in need of larger, standardised trials before firm conclusions could be drawn (PMID 30681787). In short, the direction of the published results is broadly favourable, but the strength of that evidence is moderate at best, and a narrative review of oral supplements for skin aging emphasised heterogeneity of products, endpoints and study quality as the main obstacle to interpretation (PMID 36206809).

What collagen peptides are in the cited literature

A review of hydrolyzed collagen sources and applications described hydrolyzed collagen as collagen protein broken down by enzymatic hydrolysis into low molecular weight peptides, derived most commonly from bovine, porcine, poultry or marine raw materials, and used in foods, supplements and cosmetic formulations (PMID 31703345). The same review noted that peptide profile and molecular weight vary with the source material and the hydrolysis process, which is one reason results from one preparation do not automatically transfer to another (PMID 31703345). An overview of nutricosmetics placed oral collagen within the wider category of ingested ingredients marketed for skin appearance, alongside vitamins, carotenoids and polyphenols (PMID 31478301).

Randomized controlled trials: population, comparator, endpoint, result

Two frequently cited randomized placebo controlled trials illustrate the typical design used in this field. A 2014 trial published in Skin Pharmacology and Physiology administered 2.5 g of specific bioactive collagen peptides or placebo once daily for 8 weeks to women aged 45 to 65 years and reported a statistically significant reduction in eye wrinkle volume in the treated group compared with placebo, together with increased procollagen type I and elastin content measured in skin biopsy material (PMID 24401291). A 2019 randomized, placebo controlled, blind study published in Nutrients gave a supplement containing collagen peptides combined with additional micronutrients for 12 weeks to healthy women and reported improvements in skin hydration, elasticity, roughness and density relative to placebo (PMID 31627309). Because the tested product in that study was a multi ingredient formulation, the reported changes cannot be attributed to collagen peptides alone (PMID 31627309).

Systematic reviews and meta analyses

The 2021 systematic review and meta analysis in the International Journal of Dermatology pooled randomized controlled trials of hydrolyzed collagen supplementation for skin aging and reported favourable effects on skin hydration and elasticity compared with placebo (PMID 33742704). A 2023 meta analysis in Nutrients covering oral collagen for skin anti aging reached a similar conclusion for hydration and elasticity while noting variability between the included trials (PMID 37432180). A 2023 systematic review and meta analysis published in Cureus examined hydrolyzed collagen and skin rejuvenation and also reported pooled improvements in measured skin parameters (PMID 38192916). A separate review of collagen supplementation across skin and orthopedic indications summarised the dermatological literature as suggestive of benefit for skin appearance measures while describing study quality as uneven (PMID 37064452).

How consistent are the reviews?

The reviews agree more about hydration and elasticity than about wrinkles. The 2021 pooled analysis identified hydration and elasticity as the endpoints with the most consistent signal (PMID 33742704), and the 2019 dermatological systematic review reached comparable conclusions while stressing that the underlying studies were small and used different products (PMID 30681787). A 2023 narrative review of oral supplementation and systemic drugs for skin aging placed collagen among several ingredients with supportive but not conclusive trial data (PMID 36206809).

Proposed mechanisms described by researchers

A mechanistic systematic review published in the Journal of Cosmetic Dermatology examined how ingested collagen peptides might influence skin, describing intestinal absorption of collagen derived di peptides and tri peptides such as prolyl hydroxyproline, their appearance in circulation, and laboratory evidence that such peptides can stimulate dermal fibroblast activity and extracellular matrix components (PMID 32436266). The 2014 clinical trial added human data to that picture by reporting increases in procollagen type I and elastin in skin after 8 weeks of supplementation compared with placebo (PMID 24401291). A 2024 review of collagen research in photoaged skin discussed how ultraviolet exposure degrades dermal collagen and surveyed collagen based approaches studied in that context (PMID 38009842). Mechanistic plausibility, however, is not the same as proof of clinical benefit, a distinction the mechanistic review itself drew when calling for better controlled human work (PMID 32436266).

Limitations researchers identified in this literature

• Short duration and small samples. The systematic review of dermatological applications described the included studies as small and preliminary, with results that required confirmation in larger trials (PMID 30681787).
• Narrow populations. Pooled analyses of skin aging trials drew predominantly on middle aged women, which limits generalisation to other groups (PMID 33742704).
• Heterogeneous products. Hydrolyzed collagen differs by source, molecular weight and peptide profile depending on raw material and processing (PMID 31703345), so results obtained with one preparation do not necessarily apply to another.
• Mixed formulations. Some trials tested collagen peptides alongside vitamins and other nutrients, so a single ingredient cannot be isolated as the cause of the measured change (PMID 31627309).
• Variable and partly subjective endpoints. Study outcomes ranged from instrument based corneometry and cutometry to investigator grading and participant questionnaires, and reviews flagged this inconsistency when comparing results (PMID 37432180).
• Commercial involvement. Many published trials evaluated named proprietary collagen peptide preparations, including the specific bioactive collagen peptides tested in the 2014 randomized trial (PMID 24401291); funding and conflict of interest statements are printed in each paper and are worth reading alongside the results.

Safety and Tolerability: What Studies Report

The 2019 systematic review of oral collagen in dermatology reported no adverse events in the studies it assessed (PMID 30681787). A broader review covering collagen supplementation in skin and orthopedic conditions similarly described the supplements examined as generally well tolerated in the trials reviewed (PMID 37064452). These safety observations come from short trials in mostly healthy adult volunteers, so they say little about long term use, use during pregnancy, or use by people with allergies to the source species or with medical conditions, and the review of sources and applications noted that hydrolyzed collagen is derived from bovine, porcine, poultry or marine material (PMID 31703345).

Where the evidence is weak or absent

No study in this citation set established that oral collagen peptides change clinical skin disease outcomes, and the dermatological systematic review limited its conclusions to cosmetic and appearance related measures while calling for further research (PMID 30681787). Head to head comparisons between collagen peptides and topical or procedural approaches to photoaging were not established in the reviewed literature, and the 2024 photoaging review described collagen research as an evolving field (PMID 38009842). Durability of effects after supplementation stops, optimal duration, and performance in men or in older populations remain poorly characterised, and the 2023 narrative review of oral supplements for skin aging pointed to the need for standardised, higher quality trials (PMID 36206809).

Regulatory status in the United States

In the United States, collagen peptides are sold as a dietary supplement or food ingredient, and the Food and Drug Administration does not approve dietary supplements for efficacy before they are marketed.

Reading the research critically

When comparing papers in this area, it helps to check four things in each abstract: who was enrolled, what the comparator was, which endpoint was measured and by what instrument, and how long the intervention lasted. The 2014 trial, for example, used a placebo comparator and both an imaging based wrinkle measure and tissue markers (PMID 24401291), while the 2021 meta analysis aggregated multiple such trials to estimate pooled effects on hydration and elasticity (PMID 33742704). Marketing language in the wider nutricosmetics category often outpaces the underlying data, a gap noted in a published overview of the field (PMID 31478301).

This page is for educational purposes only and is not medical advice; consult a licensed physician about any health question, supplement or medication.

Related reading

• Collagen peptides benefits: what the literature reports
• How collagen peptides are described to work
• Are peptides safe: what studies report

References

• Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis (International Journal of Dermatology, 2021)
• Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis (Nutrients, 2023)
• Oral Collagen Supplementation: A Systematic Review of Dermatological Applications (Journal of Drugs in Dermatology, 2019)
• Hydrolyzed Collagen-Sources and Applications (Molecules, 2019)
• A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study (Nutrients, 2019)
• Nutricosmetics: A brief overview (Phytotherapy Research, 2019)
• Collagen study advances for photoaging skin (Photodermatology, Photoimmunology and Photomedicine, 2024)
• Oral Supplementation and Systemic Drugs for Skin Aging: A Narrative Review (Actas Dermo-Sifiliograficas, 2023)
• Collagen supplementation in skin and orthopedic diseases: A review of the literature (Heliyon, 2023)
• Collagen supplementation for skin health: A mechanistic systematic review (Journal of Cosmetic Dermatology, 2020)
• Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis (Skin Pharmacology and Physiology, 2014)
• Exploring the Impact of Hydrolyzed Collagen Oral Supplementation on Skin Rejuvenation: A Systematic Review and Meta-Analysis (Cureus, 2023)